primary

Mallika Jaiswal

Mallika Jaiswal

Business Support Officer

Phone

44 546 073

Office location

C 146, LAS building

Mallika Jaiswal

Business Support Officer

Educational Qualifications

Bachelor of Science

Entity

College of Health and Life Sciences

Biography

Mallika is currently a Business Support Officer at the College of Health And Life Sciences, and she has developed strong management abilities while working in such a dynamic environment. 

Before joining CHLS in 2015, Mallika worked as a Program Assistant at the Executive Education Centre, where she was seconded to HEC Paris in Qatar. She has also worked within the Registrar’s Office and the Provost’s Office at HBKU. Following graduation, she came to Qatar to work as an inflight supervisor for Qatar Airways.

Mallika is active in the community and volunteers her time at local animal shelters.

 

Bachelor of Science

Executive assistant

College of Health & Life Sciences, HBKU

In-Flight Supervisor

Qatar Airways

Ranked 3rd in International Chinthana Science Examination 2003

Omar Khan

Dr. Omar Muhammad Khan

Assistant Professor

Phone

44548052

Office location

B141, 1st Floor, LAS Building, HBKU

Dr. Omar Muhammad Khan

Assistant Professor

Educational Qualifications

PhD in Molecular medicine

MSc in Molecular Cell Biology

Entity

College of Health and Life Sciences

Biography

Omar Muhammad Khan is an Assistant Professor at the College of Health and Life Sciences at Hamad Bin Khalifa University. Dr. Khan completed his Master's in Biochemistry from Karachi University, Pakistan before moving to Sweden where he did a Masters in Molecular Cell Biology from Uppsala University, and then a PhD in the lab of Prof. Martin Bergo, a protein lipidation expert. In Bergo's lab, he identified the biochemical importance of the protein lipidation enzyme GGTase-I in immune cell function. He refuted the popular idea that GGTase-I can be a therapeutic target against inflammatory conditions. 

After finishing his PhD, he moved to The Francis Crick Institute (London) in Dr. Axel Behrens's Lab, where he worked on identifying the posttranslational regulators of a tumor suppressor protein FBW7 and mechanisms of chemotherapy resistance in cancer. Dr Khan’s postdoc work highlighted the importance of protein ubiquitylation and protein turnover in colorectal cancer. He found that FBW7 which is a tumor suppressor, is posttranslationally downregulated in several colorectal cancers. These findings challenge the popular belief that only somatic loss of function mutations can contribute to cancer development.

 

PhD in Molecular medicine

Gothenburg University, Sweden

2007 – 2012

MSc in Molecular Cell Biology

Uppsala University, Sweden

2005 – 2006

MSc in Biochemistry

University of Karachi, Pakistan

2002 – 2003

Dr. Khan's research is focused on posttranslational protein modifications including ubiquitylation and deubiquitylation in cellular function and how these processes contribute to cancer growth and chemotherapy resistance. Dr. Khan identified posttranslational downregulation of FBW7 protein as a tumour promoting mechanism in colorectal cancer. Because FBW7 controls different cellular functions including stemness, cell cycle, metabolism, inflammation and cell death, it is conceivable that posttranslational stabilization of FBW7 in human cancers may block tumour progression. Consequently, Dr. Khan will exploit biochemistry, cell biology and precision medicine platforms to identify potential drug targets whose inhibition can stabilize FBW7 and improve response to chemotherapy in patients derived cancer cell lines and 3D tumour organoid models.

  • Role of protein ubiquitylation/deubiquitylation in colorectal & breast cancer
  • Control of essential cellular pathways including TGFβ & mTOR signaling by E3 ubiquitin ligases
  • Use of proteomics-based approaches to identify novel drug targets of therapeutic relevance
  • Use of 3D intestinal organoids & Apc-/- colorectal cancer models to study the underlying mechanism of cancer development and progression

Assistant Professor

College of Health and Life Sciences, Hamad Bin Khalifa University

2019 - Present

Cancer Research Senior Postdoc Fellow

The Francis Crick Institute, Cancer Research, United Kingdom

2017 - 2018

Postdoctoral Scientist

The Francis Crick Institute, Cancer Research, United Kingdom

2015 - 2017

EMBO Postdoctoral Scientist

London Research Institute, Cancer Research, United Kingdom

2013 - 2015

Keyan, K. S., Salim, S., Gowda, S., Abdelrahman, D., Amir, S. S., Vargas, C., Teresa, M. B., Alwa, A., Dahal, S., Islam, Z. U., Kolatkar, P., Das, S., Torrisani, J., Ericsson, J., Farhan, M., & Khan, O. (2023). Control of TGFβ signaling by ubiquitination independent function of E3 ubiquitin ligase TRIP12. Cell Death & Disease.

Kohil, A., Amir, S. S., Behrens, A., & Khan, O. M. (2023). A small Rho GTPase RAB25 with a potential role in chemotherapy resistance in pancreatic cancer. Cancer Biomarkers.

Keyan, K., Alanany, R., Kohil, A., & Khan, O. (2023). E3 ubiquitin ligase TRIP12 controls exit from mitosis via positive regulation of MCL-1 in response to Taxol. Cancers.

Khan, O. M., Almagro, J., Nelson, J. K., Horswell, S., Encheva, V., Keyan, K. S., Clurman, B. E., Snijders, A. P., & Behrens, A. (2021). Proteasomal degradation of the tumor suppressor E3 ubiquitin ligase FBW7 requires lysine 11-linked branched ubiquitylation by TRIP12. Nature Communications.

Brisslert, M., Brakebusch, C., Wang, D., Bokarewa, M., Sayin, V. I., & Bergo, M. O. (2019). Protein prenylation restrains innate immunity by inhibiting Rac1 effector interactions. Nature Communications.

  • March 2021– till filing, Qatar National Research Fund (Lead PI: NPRP13S, $400,000 for 4 years)
  • June 2021– 2022, Qatar National Research Fund (Research mentor: HSRP03, $5000 USD for 12-months).
  • January 2021– 2023, HBKU thematic grant in Precision Medicine (co-PI $200,000 for 2 years)
  • July 2014–June 2017, VetenskapsRådet (VR) international postdoctoral fellow in molecular biology from Gothenburg University, Sweden. (Avtals ID: D0035901, 3.1 million SEK for 3-years)
  • July 2013–June 2014, European Molecular Biology Organization’s (EMBO) postdoctoral fellow. (ID: ALTF 459-2013, GBP 28738 for 24-months)
Dr. Hibah Shaath

Dr. Hibah Shaath

Senior Research Associate

Dr. Hibah Shaath

Senior Research Associate

Educational Qualifications

PhD Biomedical and Biological Sciences

MRes Genetic Medicine

Entity

Qatar Biomedical Research Institute

Division

Translational Oncology Research Center

Biography

Dr. Hibah Shaath obtained her Bachelor of Science (Hons) and Master of Research (MRes) degrees in Genetics and Genetic Medicine from the University of Manchester. The focus of her MRes was the biomolecular characterization of Keratoconic corneas associated with transplant rejection. In 2013 she moved to Qatar and joined Shafallah Medical Genetics Center, where her main focus was identifying candidate genes with novel mutations associated with both Mendelian hereditary disease and ASD, through homozygosity mapping and family screening, presented in several posters at ARC’13 and ARC’14. In 2014, Dr. Shaath joined QBRI to work as a Research Associate in the Translational Oncology Research Center. In 2022, she completed her PhD in Biomedical and Biological Sciences from the College of Health and Life Sciences (CHLS) at HBKU under the supervision of Dr. Nehad Alajez. Her research focus is on the transcriptional landscape of colorectal cancer and breast cancer for novel biomarker discovery and targeted therapy. Her research was selected for oral presentation at the first Advances in Precision Medicine (APM 2021) conference at HBKU, and in 2022; her poster was selected for Best Poster Award in the student category as the third place winner at HBKU Research Day.

 

PhD Biomedical and Biological Sciences

College of Health and Life Sciences

September 2017 - June 2022

MRes Genetic Medicine

The University of Manchester

September 2011 - September 2012

BSc (Honors) Genetics

The University of Manchester

September 2007 - June 2010

Research Associate

Qatar Biomedical Research Institute (QBRI) - Doha, Qatar

June 2014 - Present

Research Associate

Shafallah Medical Genetics Center- Doha, Qatar

January 2013 - June 2014

Shaath H, Vishnubalaji R, Elango R, Kardousha A, Islam Z, Qureshi R, Alam T, Kolatkar PR, Alajez NM (2022). Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches. Semin Cancer Biol. 25:S1044-579X(22)00124-9.

Elango, R., Vishnubalaji, R., Shaath, H., & Alajez, N. M. (2021). Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibition. Cancer cell international, 21(1), 515.

Shaath, H., Elango, R., & Alajez, N. M. (2021). Molecular Classification of Breast Cancer Utilizing Long Non-Coding RNA (lncRNA) Transcriptomes Identifies Novel Diagnostic lncRNA Panel for Triple-Negative Breast Cancer. Cancers, 13(21), 5350.

Shaath H, Toor SM, Nada MA, Elkord E, Alajez NM (2021). Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer. Sci Rep. 11(1): p. 14456.

Shaath, H. and N.M. Alajez (2021). Identification of PBMC-based molecular signature associated with COVID-19 disease severity. Heliyon. 7(5): p. e06866.

Elango R, Vishnubalaji R, Shaath H, Alajez NM (2021). Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxel. Mol Ther Methods Clin Dev. 20: p. 601-614.

Shaath H, Vishnubalaji R, Elango R, Khattak S, Alajez NM. Single-cell long noncoding RNA (lncRNA) transcriptome implicates MALAT1 in triple-negative breast cancer (TNBC) resistance to neoadjuvant chemotherapy. Cell Death Discov. 2021 Jan 25;7(1):23. doi: 10.1038/s41420-020-00383-y. PMID: 33495450; PMCID: PMC7835365.

Shaath, H., R. Vishnubalaji, E. Elkord and N. M. Alajez (2020). "Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19." Cells 9(11).

H. Shaath, and N.M. Alajez, Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2. Biology, 2020, 9, 260.

Vishnubalaji, R., H. Shaath, and N.M. Alajez, Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response. Genes (Basel), 2020. 11(7).

Thomas, R., Shaath, H., Naik, A., Toor, S., Elkord, E. and Decock, J., 2020. Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy. Cancer Immunology, Immunotherapy, 69(3), pp.449-463.

Shaath, H., Toor, S., Nair, V., Elkord, E. and Alajez, N., 2019. Transcriptomic Analyses Revealed Systemic Alterations in Gene Expression in Circulation and Tumor Microenvironment of Colorectal Cancer Patients. Cancers, 11(12), p.1994.

Vishnubalaji, R., Shaath, H., Elango, R. and Alajez, N., 2019. Noncoding RNAs as potential mediators of resistance to cancer immunotherapy. Seminars in Cancer Biology.

Vishnubalaji, R., Shaath, H., Elkord, E. and Alajez, N., 2019. Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as a non-favorable prognostic biomarker regulated by TGFβ and focal adhesion kinase (FAK) signaling. Cell Death Discovery, 5(1).

Elashi, A., Sasidharan Nair, V., Taha, R., Shaath, H. and Elkord, E., 2018. DNA methylation of immune checkpoints in the peripheral blood of breast and colorectal cancer patients. OncoImmunology, 8(2), p.e1542918.

Sasidharan Nair, V., Toor, S., Taha, R., Shaath, H. and Elkord, E., 2018. DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer. Clinical Epigenetics, 10(1).

Lepelletier, C., Al-Sarraj, Y., Bodemer, C., Shaath, H., Fraitag, S., Kambouris, M., Hamel-Teillac, D., Shanti, H. and Hadj-Rabia, S., 2017. Heterozygous PDGFRB Mutation in a Three-generation Family with Autosomal Dominant Infantile Myofibromatosis. Acta Dermato Venereologica, 97(7), pp.858-859.

  • HBKU Research Day: Best Poster Award, Student Category; third place winner for poster on Therapeutic targeting for Colorectal Cancer: Toward Precision Medicine
  • Abstract chosen for oral presentation at the first Advances in Precision Medicine (APM 2021) conference at HBKU: Single-cell long noncoding RNA (lncRNA) transcriptome implicates MALAT1 in triple-negative breast cancer (TNBC) resistance to neoadjuvant chemotherapy
     
Tanvir Alam

Dr. Tanvir Alam

Associate Professor

Office location

A 161, 1st floor, LAS Building

Dr. Tanvir Alam

Associate Professor

Educational Qualifications

PhD in Computer Science

Entity

College of Science and Engineering

Division

Information & Computing Technology

Biography

Dr. Alam is an Associate Professor at the College of Science and Engineering. His research work is centered around the application of artificial intelligence (AI) on the diagnosis and prognosis of communicable and non-communicable diseases.

His work aims at risk factor stratification, enhancing diagnostic accuracy, and recommending personalized treatment plans for conditions such as diabetes, obesity, cardiovascular diseases, and lung cancer. His vision is to establish an AI-enabled personalized healthcare system for the community at a larger scale.

PhD in Computer Science

King Abdullah University of Science and Technology, Saudi Arabia

2016

  • Precision health
  • Artificial intelligence
  • Bioinformatics

Associate Professor

College of Science and Engineering, Hamad Bin Khalifa University

2024 - Present

Assistant Professor

College of Science and Engineering, Hamad Bin Khalifa University

2018 - 2024

Arif, M., Musleh, S., Fida, H., & Alam, T. (2024). PLMACPred: Prediction of anticancer peptides based on protein language model and wavelet denoising transformation. Scientific Reports.

Alam, T., Agrawal, S., Severin, J., Young, R. S., Andersson, R., Arner, E., Hasegawa, A., Lizio, M., Ramilowski, J., Abugessaisa, I., Ishizu, Y., Noma, S., Tarui, H., Taylor, M. S., Lassmann, T., Itoh, M., Kasukawa, T., Kawaji, H., Marchionni, L., Sheng, G., Forrest, A. R., Khachigian, L. M., Hayashizaki, Y., Carninci, P., & de Hoon, M. (2020). Comparative transcriptomics of primary cells in vertebrates. Genome Research, 30(12), 1752–1765.

de Rie, D., Abugessaisa, I., Alam, T., Arner, E., Arner, P., Ashoor, H., Åström, G., Babina, M., Bertin, N., Burroughs, A. M., Daub, C. O., Detmar, M., Deviatiiarov, R., Fort, A., Goldowitz, D., Guhl, S., Harshbarger, J., Hasegawa, A., Hashimoto, K., Heutink, P., ... Forrest, A. R. R. (2017). FANTOM5 integrated expression atlas of miRNAs and their promoters. Nature Biotechnology, 35(9), 872–878.

Hon, C. C., Ramilowski, J. A., Harshbarger, J., Bertin, N., Rackham, O. J. L., Gough, J., Denisenko, E., Schmeier, S., Poulsen, T. M., Severin, J., Lizio, M., Kawaji, H., Kasukawa, T., Itoh, M., Burroughs, A. M., Noma, S., Djebal, S. I., Alam, T., Medvedeva, Y. A., Testa, A. C., Lipovich, L., Yip, C. W., Abugessaisa, I., Mendez, M., Hasegawa, A., Tang, D., Lassmann, T., Heutink, P., Babina, M., Wells, C. A., Kojima, S., Nakamura, Y., Suzuki, H., Daub, C. O., de Hoon, M. J. L., Arner, E., the FANTOM Consortium, Hayashizaki, Y., Carninci, P., & Forrest, A. R. R. (2017). An atlas of human long non-coding RNAs with accurate 5′ ends. Nature, 543(7644), 199–204.

Alam, T., Uludag, M., Essack, M., Salhi, A., Ashoor, H., Hanks, J. B., Kapfer, C., Mineta, K., Gojobori, T., & Bajic, V. B. (2016). FARNA: Knowledgebase of annotated functions of non-coding RNA transcripts. Nucleic Acids Research, 45(D1), D130–D135.

Complete Publication Listing(s): Google Scholar

Dr. Emad Eldin Ali Shahin

Dr. Emad Eldin Ali Shahin

Professor of Islamic Studies

Office location

C.02.032

Dr. Emad Eldin Ali Shahin

Professor of Islamic Studies

Educational Qualifications

PhD in International Relations

MA Political Science and MA Equivalency in International Economics

Entity

College of Islamic Studies

Division

Islamic Studies

Biography

Dr. Emad El-Din Shahin is a professor and former dean of HBKU’s College of Islamic Studies (CIS), Qatar Foundation (2016-2022). Before joining CIS, he was the Hasib Sabbagh Distinguished Visiting Chair of Arabic and Islamic Studies, a visiting professor of Political Science at the School of Foreign Service at Georgetown University, and the editor-in-chief of The Oxford Encyclopedia of Islam and Politics

Dr. Shahin holds a PhD (1989) from the Johns Hopkins School of Advanced International Studies, and an MA (1983) and a BA (1980) from the American University in Cairo. He has taught in leading universities in the United States, including Harvard, Notre Dame, Georgetown, George Washington, and Boston Universities. He also taught at Al-Akhawayn University in Morocco.

His research and teaching interests focus on Islam and Politics, Comparative Politics, Democracy, and Political Reform in Muslim societies. Dr. Shahin has authored, co-authored, and co-edited six books and has more than 50 scholarly publications including journal articles, book chapters, and encyclopedia entries. His publications include Political Ascent: Contemporary Islamic Movements in North Africa (1998), co-editorship with Nathan Brown of The Struggle over Democracy in the Middle East and North Africa (2010); and co-authorship of Islam and Democracy (2005 in Arabic). He is the editor-in-chief of The Oxford Encyclopedia of Islam and Politics (2014) and co-editor with John L. Esposito of The Oxford Handbook of Islam and Politics (2013); Key Islamic Political Thinkers (Oxford University Press, 2018); and Islam and Politics around the World (Oxford University Press, 2018).

Dr. Shahin was nominated for the Harvard University Joseph R. Levenson Memorial Teaching Prize two years in a row, in May 2007 and May 2008, and is the recipient of the AUC Excellence in Undergraduate Teaching Award for the Academic Year 2001–2002.

PhD in International Relations

Johns Hopkins University, USA

1989

MA Political Science and MA Equivalency in International Economics

American University in Cairo/ Johns Hopkins University

1983/ 1984

BA in Political Science (Minor in Economics, Highest Honors)

The American University in Cairo, Egypt

1980

  • Islam and politics
  • Muslim political thought
  • Comparative politics
  • Democracy and political reform in Muslim societies

Faculty Affiliate

Near Eastern Languages and Civilizations Department, Harvard University

2023 – 2025

Professor of Islamic Studies

College of Islamic Studies, Hamad Bin Khalifa University

2022 – Present

Al-Shawwaf Visiting Professor

Near Eastern Languages and Civilizations Department, Harvard University

2022 – 2023

Interim Provost

Hamad Bin Khalifa University

2019 – 2021

Senior Fellow

Alwaleed Bin Talal Center for Muslim-Christian Understanding, Georgetown University

2017 – Present

Dean

College of Islamic Studies, Hamad Bin Khalifa University

2016 – 2022

Hasib Sabbagh Distinguished Visiting Professor of Arabic and Islamic Studies

School of Foreign Service, Georgetown University

2015 – 2016

Visiting Professor

School of Foreign Service, Georgetown University

2014 – 2016

Distinguished Visiting Scholar

Columbia University

2014 – 2015

Public Policy Scholar

Woodrow Wilson International Center for Scholars

2014 – 2014

Henry R. Luce Associate Professor of Religion, Conflict and Peacebuilding

Kroc Institute for International Peace Studies, University of Notre Dame

2012 - Tenured

Associate Professor

Political Science Department, University of Notre Dame

2009 – 2012

Professorial Lecturer

Boston University

2007 – 2009

Faculty Affiliate

Belfer Center for Science and International Affairs, Kennedy School of Government, Harvard University

2007 – 2008

Visiting Associate Professor

Department of Government, Harvard University

2006 - 2009

Visiting Scholar

Harvard Law School, Harvard University

2006 - 2006

Visiting Associate Professor

Center for Contemporary Arab Studies, Georgetown University

2005 - 2005

Tenured Professor

Political Science and Public Policy, The American University in Cairo

1998 – 1998

Assistant Professor

Political Science Department, Al Akhawayn University, Morocco

1996 – 1997

  • Carnegie Centennial Distinguished Visiting Scholar (May–July 2015), University of Denver
  • Distinguished Visiting Scholar, Institute for Religion, Culture and Public Life, Columbia University (April 2014–March 2015)
  • Public Policy Scholar, Woodrow Wilson International Center for Scholars (February 2014–August 2014)
  • Nominated two years in a row for the Harvard University Joseph R. Levenson Memorial Teaching Prize (May 2007 and May 2008)
  • Excellence in Undergraduate Teaching Award, American University in Cairo (2001–2002)
     
Ilham Yahya Abdi

Ilham Yahya Abdi

Research Assistant

Ilham Yahya Abdi

Research Assistant

Entity

Qatar Biomedical Research Institute

Division

Neurological Disorders Research Center

Biography

Ilham Yahya Abdi studied at the University of Westminster in London, U.K, where she completed her B.S.c in Biomedical Sciences in 2014, and her M.Sc. in Medical Molecular Sciences in 2015. For her M.Sc. research project, she studied the ‘Regulatory effects of estrogen on microglia function and behavior’. After her studies, Ilham completed a 3-month rotational training program at Hamad Medical Corporation (HMC) Pathology laboratories in Doha, in January 2018. She then continued her training at HMC were she was involved in a voluntary research internship at the Interim Translational Research Institute (iTRI) that she completed in April 2018. There she worked on various projects involving epidermal inflammation and the effects of various therapeutic agents on cutaneous inflammation under the supervision of Dr. Joerg Buddenkote. 

Ilham joined QBRI in July 2018 as a Research Assistant in Dr. Omar El Agnaf’s team. Her research interests lie in the field of neurological disorders, in particular, Alzheimer’s and Parkinson’s disease, and developing diagnostic tools for them. Her current research project is developing immunoassays and discovering novel biomarkers for Parkinson’s disease and related disorders.

Rim Mousa Bacha

Master's Student

Rim Mousa Bacha

Master's Student

Entity

Qatar Biomedical Research Institute

Division

Translational Oncology Research Center

Biography

Rim Abdul Kader Bacha is currently studying for a Master's degree in Biomedical and Biological Sciences at the College of Science and Engineering, Hamad Bin Khalifa University. She holds a Bachelor's degree in Biomedical Sciences from the College of Health Science, Qatar University. Rim received an honors for her undergraduate research project entitled “Vitamin D deficiency and oxidative stress”. Moreover, during her undergraduate studies, Rim enrolled in the undergraduate research program working on a project entitled “The Association of the Serotonin Transporter Gene Polymorphism (5-HTTLPR) and Major Depression in Qatar“. Through an internship at Hamad Medical Corporation, Rim has acquired clinical laboratory skills in haematology, immunology and clinical chemistry.

Rim recently joined Dr.Julie Decock’s team as an MSc student, where she will conduct her research work into the mechanistic basis of immune evasion in triple negative breast cancer with a particular focus on the cancer testis antigen PRAME.

 

Ghaneya Al-Khadairi

PhD Student

Ghaneya Al-Khadairi

PhD Student

Entity

Qatar Biomedical Research Institute

Division

Translational Oncology Research Center

Biography

Ghaneya Al Khadairi is currently pursuing her PhD in Biomedical and Biological Sciences at the College of Science and Engineering, Hamad Bin Khalifa University. She holds a BSc in Biomedical Sciences (Qatar University) and completed her MSc in Biomedical and Biological Sciences at Hamad Bin Khalifa University in 2017. Ghaneya was awarded a competitive graduate scholarship from the Qatar Research Leadership Program (QRLP) of Qatar Foundation, to pursue her doctoral research work as part of Dr Julie Decock’ s team.

Her PhD work focuses on the cancer testis antigen PRAME, also known as PReferentially expressed Antigen in MElanoma, and its role in the inherent aggressive behavior of triple negative breast cancer by facilitating the acquisition of several hallmarks of cancer. Findings from this project will enable us to assess whether PRAME has potential to be used as a candidate therapeutic target for triple negative breast cancer.

 

Asma Elashi

Asma Elashi

Master's Student

Asma Elashi

Master's Student

Entity

Qatar Biomedical Research Institute

Division

Translational Oncology Research Center

Biography

Ms. Asma Elashi received her Bachelor’s degree in biological sciences from Qatar University in 2017. Her research work as an undergraduate student was in cancer and her research project entitled, Investigating the effect of PRMT5 on Breast cell proliferation through β-CATENIN target gene expression. Her graduation project focused on molecular and in vitro studies in breast cancer.

Ms. Elashi is currently pursuing her Master’s in biomedical and biological science, at HBKU. She is interested to continue her research in cancer and immunotherapy. Her work now is focused on breast and colorectal cancer, as these cancers result in high mortality worldwide. Ms. Elashi’s research involves gene expression and epigenetic medications of many immune checkpoints and their associations with the aforementioned type of cancers.

 

Samia Ltaief

Samia Ltaief

Senior Research Associate

Samia Ltaief

Senior Research Associate

Entity

Qatar Biomedical Research Institute

Division

Neurological Disorders Research Center

Biography

Ms. Samia Ltaief obtained her Master's degree in Research in Life Sciences, specializing in Microbiology and Molecular Epidemiology from Sciences University of Tunis in January 2013. Her project was focused on the adaptation of BHK-21 cells in suspension culture and the study of their capacity for replication of the rabies virus. She carried out her project in the Laboratory of Molecular Microbiology, Biotechnology and Vaccine Development at the Pasteur Institute, Tunisia; she was supervised by Dr. Hella Kallel. Following the completion of her Master's degree, Ms. Ltaief worked as a Senior Lab Technician at a private medical laboratory in Tunisia for one year. She then moved to the XEN Lab of Dermocosmetic products in Tunisia in May 2014 and worked as a Quality Manager for one year. In February 2018, she joined National Center for Cancer Care and Research (NCCCR) in HMC in Qatar as a trainee, learning various immunological techniques.

Currenlty Ms. Ltaief works in QBRI as a senior research associate. Her research interest is focused on studying the role of the immune system among those with autism spectrum disorder and its correlation with neuronal phenotypes under the supervision of Dr. Abeer Al-Shammari.